Expression of dengue-3 premembrane and envelope polyprotein in lettuce chloroplasts

Plant Molecular Biology

Volumn 76, Issue 3-5, 2011, Pages 323-333

  Kanagaraj, Anderson Paul ^a   Verma, Dheeraj ^a   Daniell, Henry ^a  

^a UNIVERSITY OF CENTRAL FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

Chloroplast genetic engineering; Molecular farming; Plant made biopharmaceuticals; Viral vaccine

Indexed keywords

PRIMER DNA; VIRUS PROTEIN;

ARTICLE; CHLOROPLAST; DENGUE VIRUS; GENETICS; LETTUCE; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; SOUTHERN BLOTTING; TRANSMISSION ELECTRON MICROSCOPY; VIROLOGY; WESTERN BLOTTING;

BASE SEQUENCE; BLOTTING, SOUTHERN; BLOTTING, WESTERN; CHLOROPLASTS; DENGUE VIRUS; DNA PRIMERS; LETTUCE; MICROSCOPY, ELECTRON, TRANSMISSION; POLYMERASE CHAIN REACTION; VIRAL PROTEINS;

DENGUE VIRUS; LACTUCA; MIRIDAE;

EID: 79957851156     PISSN: 01674412     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11103-011-9766-0     Document Type: Article

References (86)

1. Arlen PA, Falconer R, Cherukumilli S, Cole A, Cole AM, Oishi KK, Daniell H (2007) Field production and functional evaluation of chloroplast-derived interferon-alpha2b. Plant Biotechnol J 5: 511-525.
2. Arlen PA, Singleton M, Adamovicz JJ, Ding Y, Davoodi-Semiromi A, Daniell H (2008) Effective plague vaccination via oral delivery of plant cells expressing F1-V antigens in chloroplasts. Infect Immun 76: 3640-3650.
3. Barrett AD (2001) Current status of flavivirus vaccines. Ann NY Acad Sci 951: 262-271.
4. Beaumier CM, Mathew A, Bashyam HS, Rothman AL (2008) Cross-reactive memory CD8(+) T cells alter the immune response to heterologous secondary dengue virus infections in mice in a sequence-specific manner. J Infect Dis 197: 608-617.
5. Blair PJ, Kochel TJ, Raviprakash K, Guevara C, Salazar M, Wu S-J, Olson JG, Porter KR (2006) Evaluation of immunity and protective efficacy of a dengue-3 premembrane and envelope DNA vaccine in Aotus nancymae monkeys. Vaccine 24: 1427-1432.
6. Blaney JE Jr, Sathe NS, Goddard L, Hanson CT, Romero TA, Hanley KA, Murphy BR, Whitehead SS (2008) Dengue virus type 3 vaccine candidates generated by introduction of deletions in the 3′ untranslated region (3′-UTR) or by exchange of the DENV-3 3′-UTR with that of DENV-4. Vaccine 26: 817-828.
7. Brayden DJ, Jepson MA, Baird AW (2005) Keynote review: intestinal Peyer's patch M cells and oral vaccine targeting. Drug Discov Today 10: 1145-1157.
8. Brightmer M, Fantato MG (1998) Human and environmental factors in the increasing incidence of dengue fever: a case study. Venezuela GeoJournal 44: 103-109.
9. Callaway E (2007) Dengue fever climbs the social ladder. Nature 448: 734-735.
10. Chambers TJ, Hahn CS, Galler R, Rice CM (1990) Flavivirus genome organization, expression, and replication. Annu Rev Microbiol 44: 649-688.
11. Chebolu S, Daniell H (2009) Chloroplast-derived vaccine antigens and biopharmaceuticals: expression, folding, assembly and functionality. Curr Top Microbiol Immunol 332: 33-54.
12. Clements DE, Coller BA, Lieberman MM, Ogata S, Wang G, Harada KE, Putnak JR, Ivy JM, McDonell M, Bignami GS, Peters ID, Leung J, Weeks-Levy C, Nakano ET, Humphreys T (2010) Development of a recombinant tetravalent dengue virus vaccine: immunogenicity and efficacy studies in mice and monkeys. Vaccine 28: 2705-2715.
13. D'Aoust MA, Couture MM, Charland N, Trepanier S, Landry N, Ors F, Vezina LP (2010) The production of hemagglutinin-based virus-like particles in plants: a rapid, efficient and safe response to pandemic influenza. Plant Biotechnol J 8: 607-619.
14. Daniell H (1997) Transformation and foreign gene expression in plants by microprojectile bombardment. Methods Mol Biol 62: 463-489.
15. Daniell H, Singh ND, Mason H, Streatfield SJ (2009) Plant-made vaccine antigens and biopharmaceuticals. Trends Plant Sci 14: 669-679.
16. Davoodi-Semiromi A, Samson N, Daniell H (2009) The green vaccine: a global strategy to combat infectious and autoimmune diseases. Hum Vaccin 5: 488-493.
17. Davoodi-Semiromi A, Schreiber M, Nalapalli S, Verma D, Singh ND, Banks RK, Chakrabarti D, Daniell H (2010) Chloroplast-derived vaccine antigens confer dual immunity against cholera and malaria by oral or injectable delivery. Plant Biotechnol J 8: 223-242.
18. De Paula SO, Lima D, Franca RFD, Gomes-Ruiz AC, da Fonseca BA (2008) A DNA vaccine candidate expressing dengue-3 virus prM and E proteins elicits neutralizing antibodies and protects mice against lethal challenge. Arch Virol 153: 2215-2223.
19. Durbin AP, Whitehead SS (2010) Dengue vaccine candidates in development. Curr Top Microbiol Immunol 338: 129-143.
20. Fernández-San Millán A, Ortigosa SM, Hervás-Stubbs S, Corral-Martínez P, Seguí-Simarro JM, Gaétan J, Coursaget P, Veramendi J (2008) Human papillomavirus L1 protein expressed in tobacco chloroplasts self-assembles into virus-like particles that are highly immunogenic. Plant Biotechnol J 6: 427-441.
21. Fonseca BA, Pincus S, Shope RE, Paoletti E, Mason PW (1994) Recombinant vaccinia viruses co-expressing dengue-1 glycoproteins prM and E induce neutralizing antibodies in mice. Vaccine 12: 279-285.
22. Freedman DO, Weld LH, Kozarsky PE, Fisk T, Robins R, von Sonnenburg F, Keystone JS, Pandey P, Cetron MS, GeoSentinel Surveillance Network (2006) Spectrum of disease and relation to place of exposure among ill returned travelers. N Engl J Med 354: 119-130.
23. Gould EA, Solomon T (2008) Pathogenic flaviviruses. Lancet 371: 500-509.
24. Grgacic EV, Anderson DA (2006) Virus-like particles: passport to immune recognition. Methods 40: 60-65.
25. Gubler DJ, Meltzer M (1999) Impact of dengue/dengue hemorrhagic fever on the developing world. Adv Virus Res 53: 35-70.
26. Guzman MG, Kouri G (2002) Dengue: an update. Lancet Infect Dis 2: 33-42.
27. Halstead SB (1988) Pathogenesis of dengue: challenges to molecular biology. Science 239: 476-481.
28. Halstead SB (2002) Dengue. Curr Opin Infect Dis 15: 471-476.
29. Halstead SB (2003) Neutralization and antibody-dependent enhancement of dengue viruses. Adv Virus Res 60: 421-467.
30. Huang Z, Elkin G, Maloney BJ, Beuhner N, Arntzen CJ, Thanavala Y, Mason HS (2005) Virus-like particle expression and assembly in plants: hepatitis B and Norwalk viruses. Vaccine 23: 1851-1858.
31. Kanamoto H, Yamashita A, Asao H, Okumura S, Takase H, Hattori M, Yokota A, Tomizawa K (2006) Efficient and stable transformation of Lactuca sativa L. cv. Cisco (lettuce) plastids. Transgenic Res 15: 205-217.
32. Kang SM, Yoo DG, Lipatov AS, Song JM, Davis CT, Quan FS, Chen LM, Donis RO, Compans RW (2009) Induction of long-term protective immune responses by influenza H5N1 virus-like particles. PLoS One 4: e4667.
33. Kelly EP, Greene JJ, King AD, Innis BL (2000) Purified dengue 2 virus envelope glycoprotein aggregates produced by baculovirus are immunogenic in mice. Vaccine 18: 2549-2559.
34. Kim MY, Yang MS, Kim TG (2009) Expression of dengue virus e glycoprotein domain III in non-nicotine transgenic tobacco plants. Biotechnol Bioprocess Eng 14: 725-730.
35. Kirnbauer R, Taub J, Greenstone H, Roden R, Dürst M, Gissmann L, Lowy DR, Schiller JT (1993) Efficient self-assembly of human papillomavirus type 16 L1 and L1-L2 into virus-like particles. J Virol 67: 6929-6936.
36. Konishi E, Fujii A (2002) Dengue type 2 virus subviral extracellular particles produced by a stably transfected mammalian cell line and their evaluation for a subunit vaccine. Vaccine 20: 1058-1067.
37. Kuhn RJ, Zhang W, Rossmann MG, Pletnev SV, Corver J, Lenches E, Jones CT, Mukhopadhyay S, Chipman PR, Strauss EG, Baker TS, Strauss JH (2002) Structure of dengue virus: implications for flavivirus organization, maturation, and fusion. Cell 108: 717-725.
38. Kumar S, Daniell H (2004) Engineering the chloroplast genome for hyperexpression of human therapeutic proteins and vaccine antigens. Methods Mol Biol 267: 365-383.
39. Kumar S, Dhingra A, Daniell H (2004) Plastid-expressed betaine aldehyde dehydrogenase gene in carrot cultured cells, roots, and leaves confers enhanced salt tolerance. Plant Physiol 136: 2843-2854.
40. Kyle JL, Harris E (2008) Global spread and persistence of dengue. Annu Rev Microbiol 62: 71-92.
41. Lai C-Y, Tsai W-Y, Lin S-R, Kao C-L, Hu H-P, King C-C, Wu H-C, Chang G-J, Wang W-K (2008) Antibodies to envelope glycoprotein of dengue virus during the natural course of infection are predominantly cross-reactive and recognize epitopes containing highly conserved residues at the fusion loop of domain II. J Virol 82: 6631-6643.
42. Lelivelt CL, McCabe MS, Newell CA, Desnoo CB, van Dun KM, Birch-Machin I, Gray JC, Mills KH, Nugent JM (2005) Stable plastid transformation in lettuce (Lactuca sativa L.). Plant Mol Biol 58: 763-774.
43. Lenzi P, Scotti N, Alagna F, Tornesello ML, Pompa A, Vitale A, De Stradis A, Monti L, Grillo S, Buonaguro FM, Maliga P, Cardi T (2008) Translational fusion of chloroplast-expressed human papillomavirus type 16 L1 capsid protein enhances antigen accumulation in transplastomic tobacco. Transgenic Res 17: 1091-1102.
44. Li L, Lok S-M, Yu I-M, Zhang Y, Kuhn RJ, Chen J, Rossmann MG (2008) The flavivirus precursor membrane-envelope protein complex: structure and maturation. Science 319: 1830-1834.
45. Limaye A, Koya V, Samsam M, Daniell H (2006) Receptor-mediated oral delivery of a bioencapsulated green fluorescent protein expressed in transgenic chloroplasts into the mouse circulatory system. FASEB J 20: 959-961.
46. Liu W, Jiang H, Zhou J, Yang X, Tang Y, Fang D, Jiang L (2010) Recombinant dengue virus-like particles from Pichia pastoris: efficient production and immunological properties. Virus Genes 40: 53-59.
47. Lorenz IC, Allison SL, Heinz FX, Helenius A (2002) Folding and dimerization of tick-borne encephalitis virus envelope proteins prM and E in the endoplasmic reticulum. J Virol 76: 5480-5491.
48. Manchester M, Steinmetz NF (2009) Viruses and nanotechnology. Curr Top Microbiol Immunol 327: 1-151.
49. Martínez CA, Topal E, Giulietti AM, Talou JR, Mason HS (2010) Exploring different strategies to express dengue virus envelope protein in a plant system. Biotechnol Lett 32: 867-875.
50. Matsui K, Gromowski GD, Li L, Schuh AJ, Lee JC, Barrett AD (2009) Characterization of dengue complex-reactive epitopes on dengue 3 virus envelope protein domain III. Virology 384: 16-20.
51. Men R, Bray M, Lai CJ (1991) Carboxy-terminally truncated dengue virus envelope glycoproteins expressed on the cell surface and secreted extracellularly exhibit increased immunogenicity in mice. J Virol 65: 1400-1407.
52. Modis Y, Ogata S, Clements D, Harrison SC (2004) Structure of the dengue virus envelope protein after membrane fusion. Nature 427: 313-319.
53. Morens DM, Fauci AS (2008) Dengue and hemorrhagic fever: a potential threat to public health in the United States. JAMA 299: 214-216.
54. Nagao Y, Koelle K (2008) Decreases in dengue transmission may act to increase the incidence of dengue hemorrhagic fever. Proc Natl Acad Sci USA 105: 2238-2243.
55. Noad R, Roy P (2003) Virus-like particles as immunogens. Trends Microbiol 11: 438-444.
56. Noble CG, Chen YL, Dong H, Gu F, Lim SP, Schul W, Wang QY, Shi PY (2010) Strategies for development of dengue virus inhibitors. Antiviral Res 85: 450-462.
57. Ocazionez Jimenez R, Lopes da Fonseca BA (2000) Recombinant plasmid expressing a truncated dengue-2 virus E protein without co-expression of prM protein induces partial protection in mice. Vaccine 19: 648-654.
58. Ooi EE, Goh KT, Gubler DJ (2006) Dengue prevention and 35 years of vector control in Singapore. Emerg Infect Dis 12: 887-893. http://www. cdc. gov/eid.
59. Osatomi K, Sumiyoshi H (1990) Complete nucleotide sequence of dengue type 3 virus genome RNA. Virology 176: 643-647.
60. Perera R, Kuhn RJ (2008) Structural proteomics of dengue virus. Curr Opin Microbiol 11: 369-377.
61. Purdy DE, Chang GJ (2005) Secretion of noninfectious dengue virus-like particles and identification of amino acids in the stem region involved in intracellular retention of envelope protein. Virology 333: 239-250.
62. Roehrig JT (2003) Antigenic structure of flavivirus proteins. Adv Virus Res 59: 141-175.
63. Ruf S, Hermann M, Berger IJ, Carrer H, Bock R (2001) Stable genetic transformation of tomato plastids and expression of a foreign protein in fruit. Nat Biotechnol 19: 870-875.
64. Ruhlman T, Ahangari R, Devine A, Samsam M, Daniell H (2007) Expression of cholera toxin B-proinsulin fusion protein in lettuce and tobacco chloroplasts-oral administration protects against development of insulitis in non-obese diabetic mice. Plant Biotechnol J 5: 495-510.
65. Ruhlman T, Verma D, Samson N, Daniell H (2010) The role of heterologous chloroplast sequence elements in transgene integration and expression. Plant Physiol 152: 2088-2104.
66. Saejung W, Fujiyama K, Takasaki T, Ito M, Hori K, Malasit P, Watanabe Y, Kurane I, Seki T (2007) Production of dengue 2 envelope domain III in plant using TMV-based vector system. Vaccine 25: 6646-6654.
67. Saldana S, Esquivel Guadarrama F, Olivera Flores Tde J, Arias N, Lopez S, Arias C, Ruiz-Medrano R, Mason H, Mor T, Richter L, Arntzen CJ, Gomez Lim MA (2006) Production of rotavirus-like particles in tomato (Lycopersicon esculentum L.) fruit by expression of capsid proteins VP2 and VP6 and immunological studies. Viral Immunol 19: 42-53.
68. Sambrook J, Russell DW (2001) Molecular cloning: a laboratory manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor.
69. Santi L, Huang Z, Mason H (2006) Virus like particles production in green plants. Methods 40: 66-76.
70. Santi L, Batchelor L, Huang Z, Hjelm B, Kilbourne J, Arntzen CJ, Chen Q, Mason HS (2008) An efficient plant viral expression system generating orally immunogenic Norwalk virus-like particles. Vaccine 26: 1846-1854.
71. Scheerlinck JP, Greenwood DL (2008) Virus-sized vaccine delivery systems. Drug Discov Today 13: 882-887.
72. Senior K (2009) Dengue vaccine efficacy trials in progress. Lancet Infect Dis 9: 662-663.
73. Singh ND, Li M, Lee SB, Schnell D, Daniell H (2008) Arabidopsis Tic40 expression in tobacco chloroplasts results in massive proliferation of the inner envelope membrane and upregulation of associated proteins. Plant Cell 20: 3405-3417.
74. Sugrue RJ, Cui T, Xu Q, Fu J, Cheong Chan Y (1997) The production of recombinant dengue virus E protein using Escherichia coli and Pichia pastoris. J Virol Methods 69: 159-169.
75. Suzuki R, Winkelmann ER, Mason PW (2009) Construction and characterization of a single-cycle chimeric flavivirus vaccine candidate that protects mice against lethal challenge with dengue virus type 2. J Virol 83: 1870-1880.
76. Takahashi I, Nochi T, Yuki Y, Kiyono H (2009) New horizon of mucosal immunity and vaccines. Curr Opin Immunol 21: 352-358.
77. Verma D, Daniell H (2007) Chloroplast vector systems for biotechnology applications. Plant Physiol 145: 1129-1143.
78. Verma D, Samson NP, Koya V, Daniell H (2008) A protocol for expression of foreign genes in chloroplasts. Nat Protoc 3: 739-758.
79. Verma D, Moghimi B, LoDuca PA, Singh HD, Hoffman BE, Herzog RW, Daniell H (2010) Oral delivery of bioencapsulated coagulation factor IX prevents inhibitor formation and fatal anaphylaxis in hemophilia B mice. Proc Natl Acad Sci USA 107: 7101-7106.
80. Walmsley AM, Arntzen CJ (2000) Plants for delivery of edible vaccines. Curr Opin Biotechnol 11: 126-129.
81. Wang SL, He RT, Anderson R (1999) PrM- and cell-binding domains of the dengue virus E protein. J Virol 73: 2547-2551.
82. Wang PG, Kudelko M, Lo J, Siu LYL, Kwok KTH, Sachse M, Nicholls JM, Bruzzone R, Altmeyer RM, Nal B (2009) Efficient assembly and secretion of recombinant subviral particles of the four dengue serotypes using native prM and E proteins. Plos One 4: e8325.
83. Webster DP, Farrar J, Rowland-Jones S (2009) Progress towards a dengue vaccine. Lancet Infect Dis 9: 678-687.
84. Whitehead SS, Blaney JE, Durbin AP, Murphy BR (2007) Prospects for a dengue virus vaccine. Nat Rev Microbiol 5: 518-528.
85. WHO (2009) Dengue guidelines for diagnosis, treatment, prevention and control. World health organization, Geneva, pp 1-147.
86. Wright PF, Durbin AP, Whitehead SS, Ikizler MR, Henderson S, Blaney JE, Thumar B, Ankrah S, Rock MT, McKinney BA, Murphy BR, Schmidt AC (2009) Phase 1 trial of the dengue virus type 4 vaccine candidate rDEN4{Delta}30-4995 in healthy adult volunteers. Am J Trop Med Hyg 81: 834-841.